🇺🇸 FDA
Patent

US 10973869

Methods of treating cardiomyopathy associated with genetic disorders

granted A61KA61K38/085A61P

Quick answer

US patent 10973869 (Methods of treating cardiomyopathy associated with genetic disorders) held by Compass Therapeutics LLC expires Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
Compass Therapeutics LLC
Grant date
Tue Apr 13 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 08 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
19
CPC classes
A61K, A61K38/085, A61P, A61P9/06